Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Operating Leases (2019 - 2026)

Mesoblast (MESO) posted Operating Leases of $5.9 million for Q4 2025, up 64.44% sequentially from $3.6 million in Q2 2025, and up 24.04% YoY from $4.8 million in Q4 2024.

Analysis

Mesoblast (MESO) Operating Leases (2019 - 2026) Analysis & Trends

Mesoblast has reported Operating Leases for 7 years, with the latest figure at $5.9 million in Q4 2025.

  • Quarterly Operating Leases rose 24.04% year-over-year to $5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.9 million (up 24.04% YoY) and the FY2025 annual result came in at $3.6 million, down 21.73% from the prior year.
  • Operating Leases rose to $5.9 million in Q4 2025 per MESO's latest filing, from $3.6 million in the prior quarter.
  • Over five years, Operating Leases peaked at $10.3 million in Q2 2022 and troughed at $3.4 million in Q4 2023.
  • A 5-year average of $6.3 million and a median of $6.3 million in 2022 frame the typical range for Operating Leases.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases sank 42.29% in 2023, then soared 40.28% in 2024.
  • Over 5 years, Operating Leases stood at $7.9 million in 2021, then slumped by 37.04% to $5.0 million in 2022, then plunged by 32.28% to $3.4 million in 2023, then surged by 40.28% to $4.8 million in 2024, then grew by 24.04% to $5.9 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods registered $5.9 million, $3.6 million, and $4.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Mesoblast 2.24 Bn 2.14 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.03 Mn
Dec 31, 2025 2.38 Mn
Jun 30, 2025 2.68 Mn
Dec 31, 2024 2.38 Mn
Jun 30, 2024 2.63 Mn
Dec 31, 2023 2.85 Mn
Jun 30, 2023 4.06 Mn
Mar 31, 2023 3.61 Mn
Dec 31, 2022 3.86 Mn
Sep 30, 2022 3.61 Mn
Jun 30, 2022 3.19 Mn
Mar 31, 2022 2.43 Mn
Dec 31, 2021 3.49 Mn
Sep 30, 2021 3.14 Mn
Jun 30, 2021 2.77 Mn
Mar 31, 2021 2.84 Mn
Dec 31, 2020 2.55 Mn
Sep 30, 2020 2.98 Mn
Jun 30, 2020 3.52 Mn
Mar 31, 2020 3.06 Mn